In Novartis AG v. Ezra Ventures, LLC, [2017-2284] (December 7, 2018), the Federal Circuit affirmed the district court’s determination that obviousness- type double patenting does not invalidate an otherwise  validly obtained patent term extension (PTE) under §156. After Ezra filed an … Continue reading Judicially Created Double Patenting Does Not Limit Statutory Patent Term Extension